Crispr Stock Jumps After Unveiling Timeline For FDA Submission Of First-Ever CRISPR Drug
Yahoo! Finance
Crispr said Tuesday it will begin asking the FDA to approve its gene-editing blood diseases treatment in November, and CRSP stock jumped.
Continue Reading